Epidemiology

You have full text access to this OnlineOpen article

Milk, milk products and lactose intake and ovarian cancer risk: A meta-analysis of epidemiological studies

  1. Susanna C. Larsson†,*,
  2. Nicola Orsini,
  3. Alicja Wolk

Article first published online: 28 JUL 2005

DOI: 10.1002/ijc.21305

Issue

International Journal of Cancer

International Journal of Cancer

Volume 118, Issue 2, pages 431–441, 15 January 2006

Additional Information

How to Cite

Larsson, S. C., Orsini, N. and Wolk, A. (2006), Milk, milk products and lactose intake and ovarian cancer risk: A meta-analysis of epidemiological studies. Int. J. Cancer, 118: 431–441. doi: 10.1002/ijc.21305

Author Information

  1. Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

  1. †

    Fax: +46-8-304571

*Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, PO Box 210, SE-171 77 Stockholm, Sweden

Publication History

  1. Issue published online: 9 NOV 2005
  2. Article first published online: 28 JUL 2005
  3. Manuscript Accepted: 20 APR 2005
  4. Manuscript Received: 12 JAN 2005

Funded by

  • Swedish Cancer Foundation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (175K)

References

  • 1
    Cramer DW. Lactase persistence and milk consumption as determinants of ovarian cancer risk. Am J Epidemiol 1989; 130: 904–10.
  • 2
    Harlow BL, Cramer DW, Geller J, Willett WC, Bell DA, Welch WR. The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer risk. Am J Epidemiol 1991; 134: 445–53.
  • 3
    Cramer DW, Xu H, Sahi T. Adult hypolactasia, milk consumption, and age-specific fertility. Am J Epidemiol 1994; 139: 282–9.
  • 4
    Larsson SC, Bergkvist L, Wolk A. Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort. Am J Clin Nutr 2004; 80: 1353–7.
  • 5
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–88.
  • 6
    Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301–9.
  • 7
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–58.
    Direct Link:
  • 8
    Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context. London: BMJ Publishing Group, 2001.
  • 9
    Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, Willett WC. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 1999; 149: 531–40.
  • 10
    Britton JA, Westhoff C, Howe GR, Gammon MD. Lactose and benign ovarian tumours in a case-control study. Br J Cancer 2000; 83: 1552–5.
  • 11
    Fairfield KM, Hunter DJ, Colditz GA, Fuchs CS, Cramer DW, Speizer FE, Willett WC, Hankinson SE. A prospective study of dietary lactose and ovarian cancer. Int J Cancer 2004; 110: 271–7.
    Direct Link:
  • 12
    Kushi LH, Mink PJ, Folsom AR, Anderson KE, Zheng W, Lazovich D, Sellers TA. Prospective study of diet and ovarian cancer. Am J Epidemiol 1999; 149: 21–31.
  • 13
    Cozen W, Peters R, Reichardt JK, Ng W, Felix JC, Wan P, Pike MC. Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States). Cancer Causes Control 2002; 13: 113–20.
  • 14
    Mori M, Miyake H. Dietary and other risk factors of ovarian cancer among elderly women. Jpn J Cancer Res 1988; 79: 997–1004.
  • 15
    Yen ML, Yen BL, Bai CH, Lin RS. Risk factors for ovarian cancer in Taiwan: a case-control study in a low-incidence population. Gynecol Oncol 2003; 89: 318–24.
  • 16
    Salazar-Martinez E, Lazcano-Ponce EC, Gonzalez Lira-Lira G, Escudero-De los Rios P, Hernandez-Avila M. Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico. Oncology 2002; 63: 151–7.
  • 17
    Goodman MT, Wu AH, Tung KH, McDuffie K, Kolonel LN, Nomura AM, Terada K, Wilkens LR, Murphy S, Hankin JH. Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol 2002; 156: 148–57.
  • 18
    McCann SE, Freudenheim JL, Marshall JR, Graham S. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr 2003; 133: 1937–42.
  • 19
    Risch HA, Jain M, Marrett LD, Howe GR. Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada). Cancer Causes Control 1994; 5: 540–8.
  • 20
    Herrinton LJ, Weiss NS, Beresford SA, Stanford JL, Wolfla DM, Feng Z, Scott CR. Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer. Am J Epidemiol 1995; 141: 407–16.
  • 21
    Cramer DW, Welch WR, Hutchison GB, Willett W, Scully RE. Dietary animal fat in relation to ovarian cancer risk. Obstet Gynecol 1984; 63: 833–8.
  • 22
    Cramer DW, Harlow BL, Willett WC, Welch WR, Bell DA, Scully RE, Ng WG, Knapp RC. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 1989; 2: 66–71.
  • 23
    Cramer DW, Greenberg ER, Titus-Ernstoff L, Liberman RF, Welch WR, Li E, Ng WG. A case-control study of galactose consumption and metabolism in relation to ovarian cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 95–101.
  • 24
    Mettlin CJ, Piver MS. A case-control study of milk-drinking and ovarian cancer risk. Am J Epidemiol 1990; 132: 871–6.
  • 25
    Engle A, Muscat JE, Harris RE. Nutritional risk factors and ovarian cancer. Nutr Cancer 1991; 15: 239–47.
  • 26
    Webb PM, Bain CJ, Purdie DM, Harvey PW, Green A. Milk consumption, galactose metabolism and ovarian cancer (Australia). Cancer Causes Control 1998; 9: 637–44.
  • 27
    Bertone ER, Hankinson SE, Newcomb PA, Rosner B, Willet WC, Stampfer MJ, Egan KM. A population-based case-control study of carotenoid and vitamin A intake and ovarian cancer (United States). Cancer Causes Control 2001; 12: 83–90.
  • 28
    Bosetti C, Negri E, Franceschi S, Pelucchi C, Talamini R, Montella M, Conti E, La Vecchia C. Diet and ovarian cancer risk: a case-control study in Italy. Int J Cancer 2001; 93: 911–5.
    Direct Link:
  • 29
    Zhang M, Yang ZY, Binns CW, Lee AH. Diet and ovarian cancer risk: a case-control study in China. Br J Cancer 2002; 86: 712–7.
  • 30
    Pan SY, Ugnat AM, Mao Y, Wen SW, Johnson KC. The Canadian Cancer Registries Epidemiology Research G. A case-control study of diet and the risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 1521–7.
  • 31
    Liu G, Hale GE, Hughes CL. Galactose metabolism and ovarian toxicity. Reprod Toxicol 2000; 14: 377–84.
  • 32
    Nagle CM, Purdie DM, Webb PM, Green A, Harvey PW, Bain CJ. Dietary influences on survival after ovarian cancer. Int J Cancer 2003; 106: 264–9.
    Direct Link:
  • 33
    McCann SE, Moysich KB, Mettlin C. Intakes of selected nutrients and food groups and risk of ovarian cancer. Nutr Cancer 2001; 39: 19–28.
  • 34
    Bertone ER, Rosner BA, Hunter DJ, Stampfer MJ, Speizer FE, Colditz GA, Willett WC, Hankinson SE. Dietary fat intake and ovarian cancer in a cohort of US women. Am J Epidemiol 2002; 156: 22–31.
  • 35
    Risch HA, Jain M, Marrett LD, Howe GR. Dietary fat intake and risk of epithelial ovarian cancer. J Natl Cancer Inst 1994; 86: 1409–5.
  • 36
    Pirozzo S, Purdie D, Kuiper-Linley M, Webb P, Harvey P, Green A, Bain C. Ovarian cancer, cholesterol, and eggs: a case-control analysis. Cancer Epidemiol Biomarkers Prev 2002; 11: 1112–4.
  • 37
    Swartz WJ, Mattison DR. Galactose inhibition of ovulation in mice. Fertil Steril 1988; 49: 522–6.
  • 38
    Reichardt JK, Woo SL. Molecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridylyltransferase. Proc Natl Acad Sci USA 1991; 88: 2633–7.
  • 39
    Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981; 304: 994–8.
  • 40
    Kaufman FR, Xu YK, Ng WG, Donnell GN. Correlation of ovarian function with galactose-1-phosphate uridyl transferase levels in galactosemia. J Pediatr 1988; 112: 754–6.
  • 41
    Morland SJ, Jiang X, Hitchcock A, Thomas EJ, Campbell IG. Mutation of galactose-1-phosphate uridyl transferase and its association with ovarian cancer and endometriosis. Int J Cancer 1998; 77: 825–7.
    Direct Link:
  • 42
    Goodman MT, Wu AH, Tung KH, McDuffie K, Cramer DW, Wilkens LR, Terada K, Reichardt JK, Ng WG. Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancer. Am J Epidemiol 2002; 156: 693–701.
  • 43
    Elsas LJ, Lai K, Saunders CJ, Langley SD. Functional analysis of the human galactose-1-phosphate uridyltransferase promoter in Duarte and LA variant galactosemia. Mol Genet Metab 2001; 72: 297–305.
  • 44
    Langley SD, Lai K, Dembure PP, Hjelm LN, Elsas LJ. Molecular basis for Duarte and Los Angeles variant galactosemia. Am J Hum Genet 1997; 60: 366–72.
View Full Article (HTML) Get PDF (175K)